AIRWAY RESISTANCE IMPROVING AGENT

PROBLEM TO BE SOLVED: To provide an airway resistance improving agent effective for treating a disease with increased airway resistance, particularly a COPD (chronic obstructive pulmonary disease) patient. SOLUTION: The airway resistance improving agent includes L-isoleucine, L-leucine, L-lysine hyd...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ISHIKAWA SHINTARO, KISHI KAZUMASA
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide an airway resistance improving agent effective for treating a disease with increased airway resistance, particularly a COPD (chronic obstructive pulmonary disease) patient. SOLUTION: The airway resistance improving agent includes L-isoleucine, L-leucine, L-lysine hydrochloride, L-threonine, L-valine, L-arginine hydrochloride, L-histidine hydrochloride, L-tryptophan, gelatin hydrolyzate, rice oil, dextrin, retinol palmitate, ergocalciferol, bisbentiamine, riboflavin, pyridoxine hydrochloride, cyanocobalamin, folic acid, sodium L-ascorbate, tocopherol acetate, phytonadione, calcium pantothenate, nicotinic acid amide, biotin, choline bitartarate, magnesium sulfate hydrate, calcium glycerophosphate, sodium dihyrogen phosphate, sodium ferrous citrate, copper sulfate, zinc sulfate hydrate, potassium iodide, manganese sulfate, and potassium chloride. COPYRIGHT: (C)2011,JPO&INPIT